PubMed:17261671 / 1080-1256
Annnotations
PubMed_ArguminSci
{"project":"PubMed_ArguminSci","denotations":[{"id":"T5","span":{"begin":0,"end":176},"obj":"DRI_Background"}],"text":"Together, these various observations have stimulated intense interest in PPARs as therapeutic targets and led to large-scale cardiovascular end-point trials with PPAR agonists."}
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T6","span":{"begin":0,"end":176},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":176},"obj":"Sentence"}],"text":"Together, these various observations have stimulated intense interest in PPARs as therapeutic targets and led to large-scale cardiovascular end-point trials with PPAR agonists."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":176},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Together, these various observations have stimulated intense interest in PPARs as therapeutic targets and led to large-scale cardiovascular end-point trials with PPAR agonists."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T2","span":{"begin":119,"end":124},"obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"Together, these various observations have stimulated intense interest in PPARs as therapeutic targets and led to large-scale cardiovascular end-point trials with PPAR agonists."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T2","span":{"begin":119,"end":124},"obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"Together, these various observations have stimulated intense interest in PPARs as therapeutic targets and led to large-scale cardiovascular end-point trials with PPAR agonists."}